These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 26311076)
1. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients. Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076 [TBL] [Abstract][Full Text] [Related]
3. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer. Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717 [TBL] [Abstract][Full Text] [Related]
4. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers. Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363 [TBL] [Abstract][Full Text] [Related]
5. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease. Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059 [TBL] [Abstract][Full Text] [Related]
6. Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer. Tao H; Tanaka T; Okabe K J Cancer Res Clin Oncol; 2017 Aug; 143(8):1449-1459. PubMed ID: 28382517 [TBL] [Abstract][Full Text] [Related]
7. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699 [TBL] [Abstract][Full Text] [Related]
8. Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer. Li L; Shen Y; Wang M; Tang D; Luo Y; Jiao W; Wang Z; Yang R; Tian K Clin Transl Oncol; 2014 Jun; 16(6):581-9. PubMed ID: 24154929 [TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer. Zhang Y; Miao Y; Yi J; Wang R; Chen L Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829 [TBL] [Abstract][Full Text] [Related]
10. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients. Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259 [TBL] [Abstract][Full Text] [Related]
11. TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer. Wu D; Xiong L; Wu S; Jiang M; Lian G; Wang M Lung Cancer; 2012 Apr; 76(1):106-11. PubMed ID: 21983100 [TBL] [Abstract][Full Text] [Related]
12. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
13. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer. Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer. Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320 [TBL] [Abstract][Full Text] [Related]
15. Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. Qu D; Johnson J; Chandrakesan P; Weygant N; May R; Aiello N; Rhim A; Zhao L; Zheng W; Lightfoot S; Pant S; Irvan J; Postier R; Hocker J; Hanas JS; Ali N; Sureban SM; An G; Schlosser MJ; Stanger B; Houchen CW PLoS One; 2015; 10(2):e0118933. PubMed ID: 25723399 [TBL] [Abstract][Full Text] [Related]
16. WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC). Baykara O; Demirkaya A; Kaynak K; Tanju S; Toker A; Buyru N Tumour Biol; 2010 Aug; 31(4):315-20. PubMed ID: 20480411 [TBL] [Abstract][Full Text] [Related]
17. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the GATA genes in lung cancer. Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625 [TBL] [Abstract][Full Text] [Related]
20. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]